Non-alcoholic fatty liver disease (NAFLD) encompasses the simple steatosis to more
progressive steatosis with associated hepatitis, fibrosis, cirrhosis, and in some cases …

Nonalcoholic fatty liver disease (NAFLD) is quickly becoming one of the most prominent
causes of liver disease worldwide. The increasing incidence of NAFLD is tied to the obesity …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most common chronic liver
disease worldwide with a reported prevalence ranging 6–33%, depending on the studied …

Non‐alcoholic fatty liver disease (NAFLD) is present in up to one‐third of the general
population and in the majority of patients with metabolic risk factors such as obesity and …

Non-alcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease that
occurs across all age groups and is recognized to occur in 14%-30% of the general …

Nonalcoholic fatty liver disease may be the most common liver disease in the United States,
with a high prevalence in the obese, type 2 diabetic population, and it is probably …

The underlying mechanism and pathogenesis of NAFLD remain elusive. Although research
effort has advanced the understanding of the natural history, pathogenesis and …

Non-alcoholic fatty liver disease (NAFLD) is now the commonest liver disorder in the
developed world affecting up to a third of individuals. It is closely associated with features of …

Nonalcoholic fatty liver disease (NAFLD) was first described as a distinct clinical entity four
decades ago. However, the condition has become the centre of attention within hepatology …

Nonalcoholic fatty liver disease (NAFLD), already the most common form of liver disease in
the United States, can be expected to increase in prevalence and severity in parallel with …